The Discounted Cash Flow (DCF) valuation of Ultragenyx Pharmaceutical Inc (RARE) is (333.34) USD. With the latest stock price at 48.86 USD, the upside of Ultragenyx Pharmaceutical Inc based on DCF is -782.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.5% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (633.04) - (230.05) | (333.34) |
| Upside | -1395.6% - -570.8% | -782.2% |